share_log

Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024

Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024

鸚鵡螺生物技術將於2024年7月30日公佈2024年第二季度財務業績。
Nautilus Biotechnology ·  07/09 00:00

SEATTLE, July 09, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single molecule protein analysis platform, today announced it will report financial results for the second quarter 2024 before market open on Tuesday, July 30, 2024.

2024年7月9日,西雅圖(全球新聞社)- 鸚鵡螺體育公司(納斯達克股票代碼:NAUT或“鸚鵡螺體育”),是一家開創性的單分子蛋白質分析平台公司,宣佈將於2024年7月30日星期二市場開盤前公佈2024年第二季度財務業績。

The company's management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the "Investors" section of the company website at: .

公司管理層將從太平洋時間早上5:30 / 東部時間早上8:30開始網絡直播相應的電話會議,以討論其業績、業務發展和前景。網絡直播的實況音頻將在公司網站的"投資者"板塊上提供:。

About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus' mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit .

關於Nautilus Biotechnology,Inc。
鸚鵡螺體育公司總部位於華盛頓州西雅圖市,研發總部位於加利福尼亞州聖卡洛斯市,是一家發展階段的生命科學公司,致力於創建一個量化和揭示蛋白質組複雜性的平台技術。鸚鵡螺體育的使命是通過民主化進入蛋白質組並在人類健康和醫學領域實現根本性的進步,來改變蛋白質組學領域。欲了解更多關於鸚鵡螺體育,請訪問.

Media Contact
press@nautilus.bio

媒體聯繫人
press@nautilus.bio

Investor Contact
investorrelations@nautilus.bio

投資者聯繫方式
investorrelations@nautilus.bio


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論